Results Snapshot
Figures in Million
Consolidate Annual Results
Feb'25
Feb'24
Feb'23
Feb'22
Feb'21
Feb'20
Feb'19
Net Sales
48,393.49
39,900.99
33,897.60
33,595.99
31,603.67
32,042.45
31,222.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
48,393.49
39,900.99
33,897.60
33,595.99
31,603.67
32,042.45
31,222.17
Raw Material Cost
42,787.68
35,520.23
30,924.16
30,223.41
28,608.82
28,794.53
28,148.91
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
63.85
54.02
50.80
58.27
53.74
59.00
61.99
Selling and Distribution Expenses
3,623.73
2,543.74
1,712.72
1,765.10
1,715.48
1,759.02
1,776.04
Other Expenses
-6.38
-5.40
-5.08
-5.83
-5.37
-5.90
-6.20
Total Expenditure (Excl Depreciation)
46,411.41
38,063.97
32,636.87
31,988.51
30,324.29
30,553.55
29,924.95
Operating Profit (PBDIT) excl Other Income
1982.1000000000001
1837
1260.6999999999998
1607.5
1279.4
1488.8999999999999
1297.2
Other Income
380.89
411.44
468.22
283.08
550.18
153.64
283.25
Operating Profit (PBDIT)
2,836.32
2,754.54
2,244.98
2,429.39
2,415.96
2,184.37
2,175.97
Interest
63.85
54.02
50.80
58.27
53.74
59.00
61.99
Exceptional Items
-107.47
-253.98
-38.82
-24.19
-82.85
-26.73
-96.53
Gross Profit (PBDT)
5,605.81
4,380.75
2,973.44
3,372.58
2,994.85
3,247.92
3,073.26
Depreciation
763.41
783.88
841.59
870.47
837.72
825.90
849.44
Profit Before Tax
1,901.59
1,662.67
1,313.76
1,476.46
1,441.65
1,272.74
1,168.00
Tax
754.47
581.07
540.48
607.08
606.66
470.75
456.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,133.17
1,039.79
759.60
852.33
834.99
801.99
711.65
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,133.17
1,039.79
759.60
852.33
834.99
801.99
711.65
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
13.95
41.81
13.69
17.05
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,147.12
1,081.60
773.29
869.38
834.99
801.99
711.65
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
14,097.86
13,240.85
12,049.33
11,383.06
10,484.83
10,170.92
9,551.94
Earnings per share (EPS)
301.35
276.71
202.2
226.92
221.31
210.37
185.95
Diluted Earnings per share
301.35
276.71
202.2
226.92
221.31
210.37
185.95
Operating Profit Margin (Excl OI)
3.5%
3.91%
2.76%
3.8%
3.25%
3.76%
3.34%
Gross Profit Margin
5.51%
6.13%
6.36%
6.99%
7.21%
6.55%
6.46%
PAT Margin
2.34%
2.61%
2.24%
2.54%
2.64%
2.5%
2.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Feb 2025 is 21.28% vs 17.71% in Feb 2024
Consolidate Net Profit
YoY Growth in year ended Feb 2025 is 6.06% vs 39.87% in Feb 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Feb 2025 is 4.79% vs 31.87% in Feb 2024
Interest
YoY Growth in year ended Feb 2025 is 18.15% vs 6.30% in Feb 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Feb 2025 has fallen from Feb 2024
Compare Annual Results Of Medical Ikkou Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(JPY)
Change(%)
Net Sales
48,393.49
1,00,174.00
-51,780.51
-51.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
48,393.49
1,00,174.00
-51,780.51
-51.69%
Raw Material Cost
42,787.68
75,882.00
-33,094.32
-43.61%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
63.85
187.00
-123.15
-65.86%
Selling and Distribution Expenses
3,623.73
22,617.00
-18,993.27
-83.98%
Other Expenses
-6.38
-18.70
12.32
65.88%
Total Expenditure (Excl Depreciation)
46,411.41
98,499.00
-52,087.59
-52.88%
Operating Profit (PBDIT) excl Other Income
1,982.08
1,675.00
307.08
18.33%
Other Income
380.89
165.00
215.89
130.84%
Operating Profit (PBDIT)
2,836.32
3,227.00
-390.68
-12.11%
Interest
63.85
187.00
-123.15
-65.86%
Exceptional Items
-107.47
-423.00
315.53
74.59%
Gross Profit (PBDT)
5,605.81
24,292.00
-18,686.19
-76.92%
Depreciation
763.41
1,387.00
-623.59
-44.96%
Profit Before Tax
1,901.59
1,229.00
672.59
54.73%
Tax
754.47
447.00
307.47
68.79%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,133.17
768.00
365.17
47.55%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,133.17
768.00
365.17
47.55%
Share in Profit of Associates
0
0
0.00
Minority Interest
13.95
13.00
0.95
7.31%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,147.12
781.00
366.12
46.88%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
14,097.86
9,796.00
4,301.86
43.91%
Earnings per share (EPS)
301.35
55.47
245.88
443.27%
Diluted Earnings per share
301.35
55.47
245.88
443.27%
Operating Profit Margin (Excl OI)
3.50%
1.67%
0.00
1.83%
Gross Profit Margin
5.51%
2.61%
0.00
2.90%
PAT Margin
2.34%
0.77%
0.00
1.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 4,839.35 Million
in Feb 2025Figures in Million
YoY Growth in year ended Feb 2025 is 21.28% vs 17.71% in Feb 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 114.71 Million
in Feb 2025Figures in Million
YoY Growth in year ended Feb 2025 is 6.06% vs 39.87% in Feb 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 245.54 Million
in Feb 2025Figures in Million
YoY Growth in year ended Feb 2025 is 4.79% vs 31.87% in Feb 2024
Annual - Interest
Interest 6.38 Million
in Feb 2025Figures in Million
YoY Growth in year ended Feb 2025 is 18.15% vs 6.30% in Feb 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.50%
in Feb 2025Figures in %
YoY Growth in year ended Feb 2025 has fallen from Feb 2024






